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236Secreted Frizzled-Related Protein 2 (sFRP2)
Functions as a Melanogenic Stimulator; the
Role of sFRP2 in UV-Induced
Hyperpigmentary Disorders
Misun Kim1,2,3, Jae Ho Han4, Jang-Hee Kim4, Tae Jun Park2,3,5 and Hee Young Kang1,2,3In this study, we found that secreted frizzled-related protein 2 (sFRP2) is overexpressed in the hyperpigmentary
skin of melasma and solar lentigo and in acutely UV-irradiated skin. To investigate the effect of sFRP2 on
melanogenesis, normal human melanocytes were infected with sFRP2-lentivirus or sh-sFRP2. It was found that
sFRP2 stimulates melanogenesis through microphthalmia-associated transcription factor and/or tyrosinase
upregulation via b-catenin signaling. The stimulatory action of sFRP2 in pigmentation was further confirmed in
melanocytes cocultured with fibroblasts and in ex vivo cultured skin. The findings suggest that sFRP2 functions
as a melanogenic stimulator and that it plays a role in the development of UV-induced hyperpigmentary
disorders.
Journal of Investigative Dermatology (2016) 136, 236-244; doi:10.1038/JID.2015.365INTRODUCTION
Wnt signaling is known to play a role in the development of
neural crest melanoblasts. Recently, increasing evidence
has highlighted the contribution of Wnt signaling in the
regulation of melanogenesis in adult melanocytes (Bellei
et al., 2011; Kim et al., 2013; Park et al., 2014;
Yamaguchi et al., 2004). Wnt/b-catenin signaling induces
the formation of a microphthalmia-associated transcription
factor (MITF)/b-catenin/lymphoid enhancer-binding factor
(LEF)-1 complex that in turn elevates the transcription of
the tyrosinase gene (Schepsky et al., 2006). Wnt3a activates
the MITF promoter and increases melanin synthesis, and
Wnt5a inhibits the proliferation and melanogenesis of
mouse melanocytes (Guo et al., 2012; Takeda et al., 2000;
Zhang et al., 2013). In addition, it has been suggested that
b-catenin also plays a key role in the physiological regu-
lation of cutaneous pigmentation, as a-melanocyte-stimu-
lating hormone reportedly stimulates Wnt/b-catenin
signaling (Bellei et al., 2011). It was also shown that UV
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nogenic proteins in normal melanocytes (Yamada et al.,
2013), thus suggesting that abnormal Wnt/b-catenin
signaling is responsible for various UV-induced pigmentary
disorders.
Wnt signaling is modulated by a number of secreted and
transmembrane Wnt inhibitors and activators (Cruciat and
Niehrs, 2013). Extracellular secreted proteins include the
Wnt inhibitory factor Dickkopf and secreted frizzled-
related proteins (sFRPs). sFRP proteins (sFRP1esFRP5)
appear to represent the largest family of Wnt modulators.
The sFRP protein family can be separated into two sub-
groups, sFRP1/2/5 and sFRP3/4, based on sequence ho-
mology studies (Kawano and Kypta, 2003). Early studies
found that sFRP binding to Wnt prevented the activation of
Wnt receptors, leading to the initial classification of sFRPs
as Wnt signaling inhibitors. However, subsequent reports
have indicated that sFRP2 is an agonist rather than an
antagonist of b-catenin that synergizes or mimics Wnt ac-
tivities (Kress et al., 2009; Lee et al., 2004; Mirotsou et al.,
2007; von Marschall and Fisher, 2010; Yamamura et al.,
2010).
Our interest in sFRP2 involves its upregulation in the
melasma, a common UV-induced hyperpigmentary disorder.
In our previous large-scale gene expression profiling using
lesional and perilesional normal skin of melasma, the sFRP2
gene was found to be one of the 20 most upregulated genes
in melasma hyperpigmented skin. The sFRP2 expression level
increased by 1.76-fold compared with perilesional normal
skin (Kang et al., 2011). A molecular network analysis of 279
differentially expressed genes identified the Wnt pathway and
the MITF-associated pathway as significantly modified path-
ways. A microarray analysis of solar lentigo also identified the
upregulation of the sFRP1 gene (Goyarts et al., 2007). We
therefore investigated the role of sFRP2 in the regulation of
skin pigmentation.uthors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
Figure 1. sFRP2 expression in
melasma, solar lentigo, and acutely
UVB-irradiated skin. (a) sFRP2
expression in melasma.
Immunohistochemical (left panel, n ¼
13), semiquantitative real-time PCR
(right upper panel, n ¼ 3), and RT-PCR
(lower right panel) analyses of sFRP2
expression were performed in lesional
and perilesional normal skin of
melasma. (b) sFRP2 expression in
solar lentigo. Immunohistochemical
(left panel, n ¼ 20) and
semiquantitative real-time PCR (right
panel, n ¼ 3) analyses of sFRP2
expression were performed in lesional
and perilesional normal skin of solar
lentigo. (c) The sun-protected back
skin of three volunteers was irradiated
with two minimal erythema doses of
UVB. The protein and mRNA
expressions of sFRP2 were analyzed
by immunohistochemical (left panel)
and real-time PCR (right panel, n ¼ 3)
analyses. Inserted DNA gel showed
representative RT-PCR data (right
lower panel). The stained area
(epidermis þ dermis) was measured in
an image analysis and presented as a
bar graph (middle panel). (d)
Semiquantitative analysis of sFRP2
staining. sFRP2 staining results were
graded 0 (no staining), 1þ (weak), 2þ
(moderate), or 3þ (strong). sFRP2,
secreted frizzled-related protein 2.
Scale bar ¼ 100 mm.
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sFRP2 expression is increased in UV-induced
hyperpigmented skin
In our previous microarray study, we found that sFRP2
expression was significantly increased at the transcriptional
level in melasma lesional skin (Kang et al., 2011; NCBI GEO
accession number GSE72140). The levels of sFRP2 expres-
sion in melasma were analyzed by immunohistochemical
staining (left and middle panel), semiquantitative real-time
PCR (right upper panel), and RT-PCR (right lower panel).
The findings revealed that in 9 of the 13 patients, sFRP2immunoreactivity was higher in the basal layer and around
fibroblasts in lesional skin (Figure 1a). An image analysis
demonstrated an increase in the stained area in hyperpig-
mented skins compared with perilesional skin in melasma
(n ¼ 13, epidermis, 0.567  0.062 vs. 0.256  0.086;
dermis, 0.052  0.017 vs. 0.019  0.012, P < 0.01). The
sFRP2 expression level was also examined with skin samples
showing solar lentigo, which is the most common photoaged
hyperpigmentary disorder. It was found that sFRP2 expression
was increased in 18 of 20 solar lentigo legions (Figure 1b, n ¼
20, epidermis, 0.483  0.089 vs. 0.262  0.081; dermis,www.jidonline.org 237
Figure 2. sFRP2 is expressed in melanocytes, keratinocytes, and fibroblasts. (a) sFRP2 expression was analyzed in cultured melanocytes, keratinocytes, and
fibroblasts by RT-PCR (left upper panel), Western blotting (left lower panel), and semiquantitative real-time PCR (right panel). The numbers indicate the sFRP2/a-
tubulin ratio and are represented as the fold induction versus melanocytes, and the values indicate the mean of three independent experiments  SD. Scale
bar ¼ 40 mm (b) Immunocytochemical analysis of sFRP2 expression in the cells. (c) Immunohistochemical staining of normal human skin. MITF (red) and sFRP2
(green) double-immunostained melanocytes (arrow) were visualized in the basal layer of the epidermis. sFRP2, secreted frizzled-related protein 2. Scale bar ¼
100 mm.
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2380.036  0.018 vs. 0.023  0.005, P < 0.01). To investigate
whether acute UV irradiation induces the expression of
sFRP2 in human skin in vivo, the sun-protected back skin of
three volunteers was irradiated with two minimal erythema
doses of UVB and skin samples were taken after UVB irra-
diation. Acute UVB irradiation on the human skin in vivo
significantly induced the mRNA and protein sFRP2 expres-
sions compared with nonirradiated skin (Figure 1c, n ¼ 3,
epidermis, 0.147  0.076 vs. 0.042  0.006; dermis, 0.028
 0.007 vs. 0.010  0.005, P < 0.01). Consistently, the
analysis of sFRP2 staining also revealed, in general, that it
was significantly stronger in melasma, solar lentigo, and
acutely UV-irradiated skin than in normal skin (Figure 1d).
These results indicate that sFRP2 expression is upregulated in
UV-induced hyperpigmented skin legions, suggesting a role
of sFRP2 in the development of hyperpigmentary disorders.
sFRP2 expression in skin cells
The endogenous expression of sFRP2 in cultured skin cells
was also investigated. Semiquantitative real-time PCR and
RT-PCR analyses showed that sFRP2 mRNA is expressed in
melanocytes, keratinocytes, and fibroblasts (Figure 2a). The
sFRP2 protein expressions in these cells were shown by
Western blot analyses (Figure 2a) and by immunocyto-
chemical staining (Figure 2b). Cytoplasmic and perinuclear
staining of sFRP2 was noted in the cells. To confirm theJournal of Investigative Dermatology (2016), Volume 136expression of sFRP2 in epidermal melanocytes in vivo, dou-
ble immunohistochemical staining was performed. The re-
sults showed that MITF (red)/sFRP2 (green) double-positive
melanocytes existed in the basal layer of the epidermis
(Figure 2c).
sFRP2 increases pigmentation in human melanocytes
To investigate the role of sFRP2 in the regulation of mela-
nogenesis, human melanocytes were infected with an sFRP2
expressing lentivirus. sFRP2 overexpression did not affect
melanocyte proliferation (Supplementary Figure S1 online);
however, it significantly increased the melanin content of the
melanocytes (Figure 3a, left panel). Consistent with the
changes in the melanin content, there was a significant in-
crease in the level of tyrosinase activity as well (Figure 3a,
right panel). The mRNA and protein expression levels of
melanogenesis-associated proteins, MITF, and tyrosinase
were significantly upregulated in cells overexpressing sFRP2
compared with cells transfected with a control virus
(Figure 3b). As melanocytes constitutively express sFRP2
(Figure 2a), the effect of the sFRP2 downregulation on
melanogenesis was also examined. As shown in Figure 3c,
the knockdown of sFRP2 using shRNA (sh-sFRP2) signifi-
cantly reduced the melanin content and tyrosinase activity in
melanocytes. The mRNA and protein levels of MITF and
tyrosinase were also significantly decreased by sFRP2
Figure 3. sFRP2 stimulates
melanogenesis in normal human
melanocytes. (a) Melanocytes were
infected with a control (Con) or
sFRP2-lentivirus (sFRP2) for 5 days
and the melanin content and
tyrosinase activity were measured.
The values indicate the mean of three
independent experiments. (b) The
expressions of MITF and tyrosinase
were examined by means of RT-PCR
(left panel), semiquantitative real-time
PCR (middle panel, n ¼ 4), and
Western blot analyses (right panel) of
sFRP2-lentivirus-expressing
melanocytes. (c) Melanocytes were
infected with an sh-control (shCon) or
with the sh-sFRP2-lentivirus (sh-
sFRP2), and the melanin content and
tyrosinase activity were analyzed. (d)
The expressions of MITF and
tyrosinase were examined by means
of RT-PCR (left panel),
semiquantitative real-time PCR
(middle panel, n ¼ 8), and Western
blot analyses (right panel) in sFRP2
knockdown melanocytes. The values
in the Western blot results indicate the
ratio of sFRP2, MITF, or tyrosinase/a-
tubulin and are represented as the fold
induction versus control or sh-control
lentivirus-infected melanocytes. The
values are the means of four
independent experiments  SD.
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affect the melanocyte cell growth (Supplementary Figure S1).
The expression of sFRP2 was strongest in the fibroblasts
among the tested cells, and fibroblasts are known to affect
melanocyte differentiation and to play a role in the devel-
opment of hyperpigmentary disorders, melasma, and lentigo
(Hirobe et al., 2013; Kang et al., 2006; Kovacs et al., 2010;
Yamaguchi et al., 2004). We therefore investigated the
paracrine effect of sFRP2 from fibroblasts on the regulation of
pigmentation. Melanocytes were cocultured with fibroblasts
infected with sh-sFRP2 or sFRP2-lentivirus in Transwell plates
(Figure 4a). sFRP2 overexpression or knockdown infibroblasts did not affect fibroblast proliferation
(Supplementary Figure S2 online). The melanin content and
tyrosinase activity levels were significantly increased in the
presence of sFRP2 overexpressed fibroblasts compared with
fibroblasts infected with a control lentivirus (Figure 4b).
Consistently, sFRP2 downregulation in the fibroblasts was
associated with decreased melanogenesis in melanocytes
(Figure 4c). We further examined whether sFRP2 affects
cutaneous pigmentation. Ex vivo human skin was maintained
in the presence of recombinant human sFRP2 (rsFRP2, 5 mg/
ml). After 3 days, in the presence of rsFRP2, the skin showed
significantly increased pigmentation compared with controlwww.jidonline.org 239
Figure 4. Fibroblast-derived sFRP2
induces pigmentation in melanocytes.
(a) Schematic drawing of the coculture
experiment. (b) Fibroblasts were
infected with a control or sFRP2
lentivirus and were then cocultured
with melanocytes for 5 days. The
melanin content and tyrosinase
activity were then measured. The
values indicate the mean of six
independent experiments  SD. (c)
Fibroblasts were infected with a
control or sh-sFRP2 lentivirus and
were then cocultured with
melanocytes. The melanin content
and tyrosinase activity were
measured. The values indicate the
mean of three independent
experiments  SD. (d) Ex vivo human
skin was maintained in the presence
of recombinant human sFRP2 (5 mg/
ml) for 3 days. The pigmentation was
visualized by Fontana-Masson
staining (left panel). The pigmented
area-to-epidermal area (PA/EA) ratio
was measured in an image analysis
(right panel). The values indicate the
mean of three independent
experiments. Scale bar ¼ 100 mm.
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240skin samples, as shown by Fontana-Masson staining
(Figure 4d). An image analysis showed an increased pig-
mented area-to-epidermal area ratio in the rsFRP2-treated
skin compared with the control skin (n ¼ 3, P < 0.01).
Taken together, these results indicate that sFRP2 has a stim-
ulatory effect on pigmentation.
sFRP2 stimulates b-catenin signaling in normal human
melanocytes
To elucidate the molecular mechanism by which sFRP2
stimulated melanogenesis, the effect of sFRP2 in the b-
catenin signaling pathway in melanocytes was examined.
sFRP2 upregulation was associated with increased levels of
the GSK3b at Ser9 residue phosphorylation, resulting in anJournal of Investigative Dermatology (2016), Volume 136increase in the b-catenin at Ser675 residue phosphorylation
and the total b-catenin level (Figure 5a). Consistently, sFRP2
knockdown significantly reduced the phosphorylation of
GSK3b at Ser9 residue and b-catenin at Ser675 residue
(Figure 5b, Supplementary Figure S3 online). We also per-
formed an LEF/T cell factor (TCF) luciferase reporter analysis
to investigate whether sFRP2 activates b-catenin signaling.
Treatment of recombinant sFRP2 (1e2 mg/ml) stimulated the
luciferase activity and green fluorescence protein expression
of melanocytes in a dose-dependent manner (Figure 5c,
Supplementary Figure S4 online). Finally, semiquantitative
real-time PCR analysis showed that the rsFRP2 or positive
control (Wnt3a) treatments upregulated the expressions of the
known Wnt target genes such as MITF, LEF-1, and c-myc
Figure 5. sFRP2 stimulates b-catenin
signaling in normal human
melanocytes. Melanocytes were
infected with (a) sFRP2 lentivirus or (b)
sh-sFRP2 lentivirus for 3 days. The
expressions of GSK3bS9 and b-catenin
were analyzed by Western blot
analysis. The numbers indicate the
ratio of sFRP2, GSK3bS9, GSK3b,
b-catenineS675, or b-catenin/a-tubulin
and are represented as the fold
induction versus control or sh-control
lentivirus-infected melanocytes, and
the values indicate the mean of three
independent experiments  SD. (c)
An LEF/TCF reporter luciferase assay
was performed using melanocytes
treated with 1e2 mg/ml of rhsFRP2.
The data show the mean of four
independent experiments. The
localization of b-catenin was
analyzed using a confocal microscope
in (d) melanocytes that overexpress
sFRP2 and in (e) melanocytes in
melasma lesional skin. The
intranuclear staining of b-catenin
(arrowheads) was observed in the
melasma melanocytes. The arrow
indicates the plasma-membrane-
localized b-catenin in normal skin
melanocytes. Scale bar ¼ 40 mm.
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(Supplementary Figure S4). The result of b-catenin stabiliza-
tion in the cells is nuclear translocation, where it acts as a
transcriptional cofactor (MacDonald et al., 2009). A confocal
microscopic examination showed a significantly increased
proportion of nuclear b-catenin in melanocytes that over-
express sFRP2 (Figure 5d, 22.9% vs. 56.2%) and melanocytes
in melasma lesional skin in vivo (Figure 5e, 20.0% vs.
41.7%). These data strongly suggest that the increased
expression of sFRP2 activates b-catenin signaling in mela-
nocytes, resulting in increased melanogenesis.
DISCUSSION
In this study, we demonstrated that sFRP2 expression is higher
in the lesional skins of melasma and solar lentigo. We also
found that acute UV irradiation increases mRNA and protein
expressions of sFRP2 in human skin in vivo. On the basis of
its overexpression in hyperpigmented skin in vivo, we hy-
pothesized that sFRP2 stimulates melanogenesis. We report
here that sFPR2 is a stimulator of melanogenesis in normalhuman melanocytes. Moreover, there was increased
epidermal pigmentation of human skin in the presence of
recombinant human sFRP2. These results indicate that UV
irradiation may stimulate sFRP2 secretion in the skin and that
sFRP2 functions as melanogenic stimulator. This may play an
important role in the development of UV-induced hyper-
pigmentary disorders, melisma, and solar lentigo.
In the skin, the role of sFRP2 was previously observed
during the epithelial-mesenchymal interaction in the hair
follicle (Kim and Yoon, 2014; Rendl et al., 2005). It was
shown that sFRP2 is expressed in the dermal papilla and in
the matrix of hair follicles (Rutberg et al., 2006). Another
study showed that sFRP2 expression was significantly
increased in hypertrophic tissues (Sun et al., 2011). It was
suggested that sFRP2 acts during the formation of scars or
keloids by contributing to collagen protein synthesis and
suppressing fibroblast apoptosis (Chen et al., 2012). In this
study, we demonstrated that sFRP2 is expressed both in the
epidermis and dermis of human normal skin and that skin
cells (melanocytes, keratinocytes, and fibroblasts) expresswww.jidonline.org 241
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242sFRP2 constitutively. An interesting finding was that sFRP2
immunoreactivity was intense around fibroblasts in acute
UV-irradiated skin and in lesional skin with melasma and
solar lentigo. Moreover, when the fibroblasts were exposed to
UVB irradiation, the sFRP2 expression was significantly
upregulated (Supplementary Figure S5 online). A coculture
experiment with sFRP2 over/downexpressed fibroblasts
demonstrated that fibroblast-derived sFRP2 increased
pigmentation in normal human melanocytes. These findings
suggested a certain paracrine role of fibroblast-derived sFRP2
in the regulation of the pigmentation and development of
UV-induced hyperpigmentary disorders. It is speculated that
UV irradiation may regulate sFRP2 expression in fibroblasts
and that the sFRP2 expression level may be involved in the
regulation of skin pigmentation through epithelial-
mesenchymal crosstalk. Indeed, interactions between mela-
nocytes and fibroblasts during the regulation of pigmentation
have been highlighted (Abdel-Malek et al., 2010; Hirobe
et al., 2013). Specifically, an important role of fibroblast-
derived secreted factors in the development of UV-
associated hyperpigmentary disorders, solar lentigo, or
melasma has been suggested (Choi et al., 2015; Kang et al.,
2006; Kovacs et al., 2010; Lin et al., 2010; Salducci et al.,
2014). For example, the upregulation of fibroblast-derived
stem cell factor in melasma was shown (Kang et al., 2006).
The factors secreted by UV-irradiated aged fibroblasts
induced phenotype of solar lentigo in reconstructed
epidermis (Salducci et al., 2014) and the roles of stem cell
factor, hepatocyte growth factor, or keratinocyte growth fac-
tor have been suggested (Kovacs et al., 2010; Lin et al., 2010).
Further studies are necessary to elucidate the combined roles
of sFRP2 and the secreted factors as well as other fibroblast-
derived Wnt modulators such as Wnt inhibitory factor-1 or
Dickkopf-related protein-1 during the development of
hyperpigmentary disorders (Park et al., 2014; Yamaguchi
et al., 2004).
This study also provides the evidence showing that in
normal human melanocytes, sFRP2 behaves as a positive
regulator of the canonical Wnt pathway by stabilizing b-
catenin signaling. The increased level of the active form of b-
catenin was shown by sFRP2 expression in cells and in
melasma lesional skin in vivo. Furthermore, sFRP2 signifi-
cantly increased the expressions of MITF, LEF-1, and c-myc,
which are known downstream target genes of b-catenin.
Increasing evidence has highlighted the positive role of
sFRP2 as an agonist of b-catenin. Mouse intestine studies
showed that thyroid hormone induces sFRP2 expression,
which stabilizes b-catenin, activates its target genes, and
enhances cell proliferation in the intestinal epithelium (Kress
et al., 2009). A monoclonal antibody to sFRP2 inhibited the
activation of b-catenin in endothelial cells, suggesting
the antitumor and antiangiogenic effect in vitro (Fontenot
et al., 2013). The sFRP2 enhancement of Wnt3a-mediated
b-catenin activation was also shown in human embryonic
kidney cells (von Marschall and Fisher, 2010). It has been
shown that sFRP2 action on Wnt/b-catenin appears differ-
ently depending on the cellular/tissue system. It is also sug-
gested that the uses of primary normal human melanocytes
with interdonor variability and different culture conditions of
the cells may contribute to different sFRP2 action.Journal of Investigative Dermatology (2016), Volume 136How sFRP2 stimulates b-catenin signaling in normal me-
lanocytes is unknown. The direct interaction of sFRP2 with
the frizzled receptor was proposed to activate b-catenin
(Kress et al., 2009; Skah et al., 2015). It was also suggested
that the sFRP family encourages Wnt-Frizzled receptor
interaction and enhances the diffusion of Wnt proteins by
mediating extracellular complex formation (Esteve et al.,
2011; MacDonald et al., 2009; Mii and Taira, 2009). The
precise molecular mechanism responsible for the sFRP2-
mediated augmentation of canonical signaling in melano-
cytes is needed to be further investigated.
Other regulatory stimuli acting on sFRP2 expression in the
skin apart from UV require further investigation. It was shown
that sFRP2 expression could be stimulated with estrogen
(Zhang et al., 2013). Because melasma is common during
pregnancy or with oral contraceptive use, and because it is
less common in men, it is possible that sFRP2 is differentially
regulated in men and women. In addition, keratinocyte-
derived sFRP2 may play a role in the pathophysiology of
cutaneous pigmentation. Their functional roles should be
investigated more as well. A relationship between b-catenin/
Wnt signaling and a-melanocyte-stimulating hormone/cAMP
signaling from keratinocytes during the regulation of
epidermal melanogenesis has also been found (Bellei et al.,
2011).
In summary, this study showed that sFRP2 functions as a
melanogenic stimulator through b-catenin signaling in
normal human melanocytes. On the basis of its over-
expression in melasma, solar lentigo, and acutely UV-
irradiated skin, sFRP2 may play a role in the development
of UV-induced hyperpigmentary disorders. This may provide
valuable information regarding the development of target
proteins for treatment as well as a better understanding of the
pathophysiology of cutaneous pigmentation.
MATERIALS AND METHODS
Cell culture
Normal human melanocytes, keratinocytes, and fibroblasts were
isolated from the foreskin. Melanocytes at passages 2e7 were
maintained in the F12 medium including 10% heat-inactivated fetal
bovine serum (Gibco-BRL, Bethesda, MD), 24 mg/ml 3-isobutyl-1-
methylxanthine, 80 nM 12-O-tetradecanoyl-phorbor-13-acetate,
1.2 ng/ml basic fibroblast growth factor, and 0.1 mg/ml cholera toxin
(Sigma, St. Louis, MO). The keratinocytes at passage 2 were grown in
the Epilife medium supplemented with Human Keratinocyte Growth
Supplement (Gibco-BRL). The fibroblasts at passage 2 or 5 were
maintained in Dulbecco’s modified Eagle’s medium (Gibco-BRL)
supplemented with 10% fetal bovine serum. sFRP2 overexpressed or
knockdown fibroblasts (3.5  104) were seeded in the insert Trans-
well chambers (Corning, Tewksbury, MA), and melanocytes (1 
105) were seeded at the bottom of six-well plates. After 24 hours, the
insert chambers were translocated into melanocyte seeded in six-
well plates and then maintained with the melanocytes culture me-
dium for 5 days. The insert with fibroblasts was changed to a fresh
one at 3 days.
Biopsy collection
Twenty patients with facial solar lentigo and 13 with melasma were
enrolled. All subjects were Fitzpatrick skin type III or IV, and the
average ages of solar lentigo and melasma groups were 47 and 40
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examination and confirmed with histopathological findings. Skin
biopsy samples (2 mm) were obtained from lesional and adjacent
perilesional normal skin (usually within 1 cm from the lesion
margin) from all patients. The sun-protected back skin of three men
volunteers of Fitzpatrick skin type III or IV (mean age 35 years) was
irradiated with two minimal erythema doses of UVB. Skin biopsy
samples (3 mm) were obtained (mRNA; 24 hours, immunohisto-
chemistry; 48 hours after UVB irradiation) and snap-frozen in liquid
nitrogen immediately after resection. Informed written consent was
obtained from each patient before skin biopsy, and this study was
approved by the Institutional Review Board of Ajou University
Hospital (AJIRB-GEN-GEN-10-319).
Ex vivo skin organ culture and pigmentation assay in
cultured skin
Skin samples were obtained during surgery and cultured as previ-
ously described (Moll et al., 1998). A sterilized stainless steel grid
was placed on a six-well plate and the skin specimens were placed
on the stainless steel grid. Dulbecco’s modified Eagle’s medium
supplemented with 5% fetal bovine serum was filled up to the
stainless steel grid. After 3 days of culture with 5 mg/ml rhsFRP2
(R&D Systems, Minneapolis, MN) in an incubator at 37 C with 5%
CO2, the specimens were fixed in 10% formalin and embedded in
paraffin section. Melanin was detected with Fontana-Masson stain-
ing. Image analysis was performed using Image Pro Plus V4.5 (Media
Cybernetics, Rockville, MD) and the pigmented area-to-epidermal
area ratio was measured.
Melanin content and tyrosinase activity assay
The cells were lysed with a 0.1 M phosphate buffer (pH 6.8) con-
taining 1% Triton X-100 with a protease inhibitor cocktail (Roche,
Basel, Switzerland). The supernatants were measured to determine
the protein concentration using the Lowry assay. For melanin content
assay, pellets were solubilized with 1 N NaOH. The absorbance at
490 nm was compared with a standard curve of synthetic melanin
(Sigma) using an ELISA reader (Model 680, Bio-Rad, Hercules, CA).
For the assay of the tyrosinase activity, each sample was incubated
with 2 mM L-DOPA (Sigma) in a 0.1 M phosphate buffer (pH 6.8) for
90 minutes at 37 C. After incubation, the tyrosinase activity was
measured at 490 nm. The tyrosinase activity and melanin content
were normalized to the protein content of each sample.
Lentivirus production
The human sFRP2 cDNA was cloned in our laboratory and sFRP2
shRNA was purchased from Sigma. The detailed methods were
described in Supplementary information online.
Semiquantitative real-time PCR and RT-PCR
Cells were seeded in 60-mm culture dishes at 1.5 105 cells and
grown to confluency. Total cellular RNA was extracted using an
RNeasy Mini Kit (Qiagen, Valencia, CA), and the cDNA was ob-
tained using a SuperScript III Reverse Transcriptase kit (Invitrogen,
Waltham, MA). Semiquantitative real-time PCR and RT-PCR were
performed as described in Supplementary Materials and Methods
online. The real-time PCR data set was provided as Supplementary
information.
Western blot analysis
Cells were lysed in radioimmunoprecipitation assay buffer (1% NP-
40, 150 mM NaCl, 10 mM Tris-HCl [pH 8.0], 1 mM EDTA) with
complete protease inhibitor cocktail tablets (Roche). The proteins
were separated by SDS-polyacrylamide gel and transferred to apolyvinylidene difluoride membrane (Millipore, Billerica, MA).
Antibody against MITF was purchased from Abcam (Cambridge,
UK); sFRP2, tyrosinase, and b-catenin were purchased from Santa
Cruz Biotechnology (Dallas, TX); GSK3b and GSK3bS9 were pur-
chased from Cell Signaling Technology (Danvers, MA); b-cateninS675
was purchased from Novus Biologicals (Littleton, CO), and a-tubulin
was purchased from Sigma.
Immunohistochemistry and confocal microscopic
examination
Lab-Tek chambers (Nalge Nunc International, Rochester, NY) were
used for immunocytochemistry. Immunohistochemical staining was
performed on 4-mm-thick representative tissue sections of formalin
fixed paraffin-embedded tissue section. Two pathologists (JHK and
JHH) analyzed the staining results with unblinded slides and graded
0 (no staining), 1þ (weak), 2þ (moderate), or 3þ (strong). Antibodies
utilized were described in Supplementary Material and Methods.
Promoter analysis
The reporter construct containing LEF/TCF luciferase was generated
in our laboratory by inserting six copies of response element in the
lentivirus pGreenFire vector, which contained luciferase and green
fluorescence protein as a reporter (System Biosciences). After
generating lentivirus particles in human embryonic kidney 293TN
cells, melanocytes were infected by LEF/TCF or control luciferase/
green fluorescence protein lentivirus. The cells were treated with
1e2 mg/ml of rhsFRP2 for 2 days. The luciferase activity was
analyzed using a Synergy 2 luminometer (BioTek, Winooski, VT)
according to the instruction for the luciferase reporter assay system
(Promega, Madison, WI). To further verify the promoter activity, we
conducted a real-time PCR analysis of the green fluorescence pro-
tein expression after treatment with rhsFRP2.
Statistical analysis
Statistical significance was tested with one-way analysis of variance
(SPSS 12.0; SPSS, Chicago, IL). A P-value of less than 0.05 is
considered statistically significant. All results are presented as
means  SD.
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